For women with low-risk DCIS features, including low-to-intermediate grade and estrogen receptor [ER]-positive status, their risk of progression to iIBC remains low [7] enough to make them an ideal group to consider the option of AS. This evidence concerns the gene ESR1 and ductal breast carcinoma in situ.